Acadia Pharma (ACAD) Tops Q2 EPS by 2c, provides guidance
Go back to Acadia Pharma (ACAD) Tops Q2 EPS by 2c, provides guidance| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 28.89 -0.02 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.91 | 52 Week High | $42.49 | |||
| Open | $28.84 | 52 Week Low | $16.64 | |||
| Day High | $29.30 | P/E | N/A | |||
| Day Low | $28.51 | EPS | $-0.42 | |||
| Volume | 830,929 | |||||

